What Three Encompass Health Insiders Selling Signals After a Rate Increase
This sale reduced an insider's direct equity holdings by 11%.
Three Encompass Health insiders sold shares following a rate increase, as reported by an SEC Form 4 filing. John Patrick Darby, EVP and general counsel of the company, sold 8,906 shares on August 10. The transaction value was calculated based on a weighted average sale price of $125.95, while the post-transaction value was determined using the market close price of $125.81 on the same day.
Encompass Health Corporation, a major player in the post-acute healthcare sector, boasts a market capitalization of $12.5 billion and generated $6.2 billion in TTM revenues. The company's diversified business model, spanning inpatient facilities and home health services, offers revenue stability and exposure to the expanding demand for post-acute care, driven by an aging population and the trend towards value-based care delivery.
With more than 42,000 employees and a solid net income margin of about 10% on TTM revenues, Encompass Health maintains operational scale and profitability in a fragmented market, where consolidation opportunities abound.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
